Summit Creek Advisors LLC decreased its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 17.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 152,442 shares of the health services provider’s stock after selling 31,560 shares during the quarter. LHC Group comprises 3.0% of Summit Creek Advisors LLC’s holdings, making the stock its 7th largest position. Summit Creek Advisors LLC owned 0.49% of LHC Group worth $16,900,000 as of its most recent filing with the SEC.
Other institutional investors also recently made changes to their positions in the company. Sageworth Trust Co purchased a new position in LHC Group during the first quarter worth approximately $36,000. Financial Gravity Companies Inc. acquired a new stake in LHC Group during the fourth quarter worth $49,000. Private Capital Group LLC increased its stake in LHC Group by 60.2% during the fourth quarter. Private Capital Group LLC now owns 897 shares of the health services provider’s stock worth $84,000 after acquiring an additional 337 shares during the last quarter. Quantamental Technologies LLC acquired a new stake in LHC Group during the fourth quarter worth $182,000. Finally, CIBC Asset Management Inc acquired a new stake in LHC Group during the fourth quarter worth $203,000. Hedge funds and other institutional investors own 93.36% of the company’s stock.
Several equities research analysts have issued reports on the company. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, April 10th. BidaskClub cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 27th. Barclays raised their target price on LHC Group from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 21st. Robert W. Baird raised their target price on LHC Group from $98.00 to $120.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. Finally, SunTrust Banks raised their target price on LHC Group to $130.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Six analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $113.25.
In related news, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction on Friday, March 1st. The stock was sold at an average price of $108.53, for a total value of $8,139,750.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Keith G. Myers sold 5,164 shares of LHC Group stock in a transaction on Wednesday, April 3rd. The shares were sold at an average price of $108.75, for a total value of $561,585.00. Following the completion of the transaction, the chief executive officer now owns 96,315 shares of the company’s stock, valued at $10,474,256.25. The disclosure for this sale can be found here. Insiders sold 192,876 shares of company stock valued at $20,614,290 over the last ninety days. Insiders own 6.80% of the company’s stock.
Shares of NASDAQ LHCG traded up $1.62 during trading on Monday, reaching $108.05. The stock had a trading volume of 3,340 shares, compared to its average volume of 223,244. LHC Group, Inc. has a fifty-two week low of $67.72 and a fifty-two week high of $115.54. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $3.34 billion, a PE ratio of 30.30, a PEG ratio of 1.87 and a beta of 0.91.
LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Wednesday, February 27th. The health services provider reported $1.03 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.03. LHC Group had a return on equity of 8.40% and a net margin of 3.50%. The business had revenue of $509.80 million during the quarter, compared to analysts’ expectations of $522.21 million. During the same period in the previous year, the firm posted $0.62 earnings per share. The company’s revenue was up 75.1% on a year-over-year basis. On average, equities analysts predict that LHC Group, Inc. will post 4.2 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This piece was first published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.thelincolnianonline.com/2019/04/15/lhc-group-inc-lhcg-position-reduced-by-summit-creek-advisors-llc.html.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
Read More: How Buying a Call Option Works
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.